Contract Research & Services
Contract Services

Contract Services News

View news from other Pharmaceutical sectors:
76-90 of 2371 results
Kite Pharma announces exclusive license with NIH for anti-CD19 CAR product candidate
Kite Pharma has entered into an exclusive, worldwide license with the National Institutes of Health (NIH) for intellectual property related to a fully human anti-CD19 chimeric antigen receptor-based product candidate directed against B-cell malignancies.
Contract Research & Services > Contract Services > News
Trek Therapeutics acquires two antiviral inhibitors from Vertex Pharmaceuticals
Trek Therapeutics has acquired the worldwide development and commercialization rights to treat infectious disease with lomibuvir (VX-222), a non-nucleoside inhibitor of the HCV NS5B polymerase and merimepodib (VX-497), an inhibitor of inosine monosphosphate dehydrogenase with broad-spectrum antiviral properties from Vertex Pharmaceuticals.
Contract Research & Services > Contract Services > News
Chugai, Galderma sign license deal for nemolizumab
Chugai Pharmaceutical and Galderma Pharma have entered into a global license agreement for “nemolizumab” (CIM331) the anti-IL-31 receptor A humanized monoclonal antibody created by Chugai, which is currently under development for atopic dermatitis and pruritus in hemodialysis patients.
Contract Research & Services > Contract Services > News
Sapience Therapeutics signs license deal with Columbia University for novel cancer treatment
Sapience Therapeutics has entered into an exclusive license agreement with Columbia University to develop a first-in-class cancer treatment, which the Company refers to as ST-36.
Contract Research & Services > Contract Services > News
Stellar Biotechnologies, Neovacs establish new company in France
Stellar Biotechnologies and Neovacs announced the formation of Neostell, a simplified stock corporation headquartered in France, to carry out the business of the companies' joint venture, previously announced on May 11, 2016, to manufacture and sell conjugated therapeutic vaccines using Stellar's Keyhole Limpet Hemocyanin (KLH).
Contract Research & Services > Contract Services > News
GSK licenses intellectual property for respiratory disease target identified using Five Prime's platform
Five Prime Therapeutics announced that GSK exercised its option to take an exclusive license to the intellectual property related to a target under the respiratory diseases research collaboration between the companies, triggering a $1.5m license payment to Five Prime.
Contract Research & Services > Contract Services > News
RedHill Biopharma announces research collaboration with NIH for potential Ebola treatment
RedHill Biopharma signed a research collaboration agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), intended to evaluate RedHill’s proprietary experimental therapy for the treatment of Ebola virus disease.
Contract Research & Services > Contract Services > News
Amgen, Daiichi Sankyo sign deal to commercialize biosimilars in Japan
Amgen and Daiichi Sankyo Company have signed an exclusive agreement to commercialize nine biosimilars in Japan.
Contract Research & Services > Contract Services > News
Aphios secures subcontract for nanoformulation of super hydrophobic anticancer drug
Aphios has been awarded a subcontract for the nanoformulation of a super hydrophobic anticancer drug administered through the Frederick National Laboratory for Cancer Research in Frederick, MD.
Contract Research & Services > Contract Services > News
Cantabio signs deal with PRF to advance development work on targeting DJ-1 protein small molecule pharmaceutical chaperone drug candidates
Cantabio Pharmaceuticals has signed an agreement with Purdue Research Foundation (PRF) to advance the company’s development work on targeting DJ-1 protein small molecule pharmaceutical chaperone drug candidates for the treatment of Parkinson’s Disease (PD) and other related neurodegenerative diseases.
Contract Research & Services > Contract Services > News
BioInvent forms process development and manufacturing collaboration with Alligator
BioInvent International has signed an agreement with Alligator Bioscience to provide process development and manufacturing services for Alligator’s new bispecific antibody, ADC-1015.
Contract Research & Services > Contract Services > News
TiGenix licenses ex-US rights for Cx601 stem cell treatment to Takeda
By PBR Staff Writer
TiGenix has sold to Takeda Pharmaceutical ex-US rights to its stem cell treatment Cx601 for complex perianal fistulas in patients with Crohn's disease.
Contract Research & Services > Contract Services > News
IntelGenx, RedHill Biopharma sign deal with Grupo Juste for commercialization of RIZAPORT
IntelGenx and RedHill Biopharma signed a definitive agreement with Grupo Juste for the commercialization of RIZAPORT, a unique oral thin film for the treatment of acute migraines, in the country of Spain.
Contract Research & Services > Contract Services > News
Aeterna Zentaris, Orient EuroPharma sign exclusive license deal for Zoptrex in Taiwan and Southeast Asia
Aeterna Zentaris has signed an exclusive license agreement with Cyntec, an affiliate of OEP (“Cyntec”), for its lead anti-cancer compound, Zoptrex (zoptarelin doxorubicin), for the initial indication of endometrial cancer, for Taiwan and nine countries in Southeast Asia (the “Territory”).
Contract Research & Services > Contract Services > News
BIND Therapeutics files motion for sale of assets after accepting stalking horse bid from Pfizer
BIND Therapeutics has filed a motion for court approval of a stalking horse asset purchase agreement bid from Pfizer for the purchase of the majority of BIND's assets.
Contract Research & Services > Contract Services > News
76-90 of 2371 results